Cargando…
P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431171/ http://dx.doi.org/10.1097/01.HS9.0000971556.88755.03 |
| _version_ | 1785091137926594560 |
|---|---|
| author | Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin |
| author_facet | Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin |
| author_sort | Zhang, Yan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431171 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311712023-08-17 P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431171/ http://dx.doi.org/10.1097/01.HS9.0000971556.88755.03 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA |
| title | P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA |
| title_full | P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA |
| title_fullStr | P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA |
| title_full_unstemmed | P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA |
| title_short | P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA |
| title_sort | p1165: preliminary findings of a phase ⅱ study of chemo-free combination of pomalidomide, orelabrutinib, rituximab with sequential high-dose methorexate in newly diagnosed primary cns lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431171/ http://dx.doi.org/10.1097/01.HS9.0000971556.88755.03 |
| work_keys_str_mv | AT zhangyan p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT chenchao p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT zhaodanqing p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT zhuangzhe p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT weichong p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT wangwei p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT zhangwei p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma AT zhoudaobin p1165preliminaryfindingsofaphaseiistudyofchemofreecombinationofpomalidomideorelabrutinibrituximabwithsequentialhighdosemethorexateinnewlydiagnosedprimarycnslymphoma |